| 22-May-13 07:30AM | Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye PR Newswire |
| 17-May-13 09:16AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 14-May-13 01:04PM | RIGEL PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 09-May-13 04:29PM | 3 Drug Catalysts to Watch in 2013 at Motley Fool |
| 07-May-13 09:08AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 07:30AM | Rigel Announces First Quarter 2013 Financial Results PR Newswire |
| 05:56AM | RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04-May-13 08:00AM | April's Unhealthiest Stocks at Motley Fool |
| 03-May-13 04:25PM | Rigel Pharmaceuticals Becomes Oversold (RIGL) at TheStreet |
| 02-May-13 12:19AM | 3 Biggest Biotech Crashes in April at Motley Fool |
| 30-Apr-13 11:49AM | Expert Analyst Ian Somaiya Discusses the Decline in European Drug Pricing with The Wall Street Transcript; Models a 1% to 2% Annual Decline in Price for Companies That Sell Overseas Wall Street Transcript |
| 18-Apr-13 09:22PM | 5 Health Care Stocks Under $10 Ready to Rip Higher at TheStreet |
| 12-Apr-13 01:32PM | 5 Stocks Poised for Breakouts at TheStreet |
| 08-Apr-13 06:05PM | AZN Reports Data on Fostamatinib Zacks |
| 04:22PM | On The Fly: Closing Wrap theflyonthewall.com |
| 11:03AM | Small Pharma Watch List: Week Of April 8, 2013 at Seeking Alpha |
| 09:47AM | Why Rigel Is Poised to Bounce Back at Motley Fool |
| 09:02AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:00AM | Hot Stock Minute: Earnings Season Kicks Off; Nikkei Up, Up, and Away Hot Stock Minute |
| 06-Apr-13 12:30PM | This Week in Biotech at Motley Fool |
| 05-Apr-13 05:52PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool -40.24% |
| 04:22PM | On The Fly: Closing Wrap theflyonthewall.com |
| 01:12PM | Growing Aches and Pains Sink Rigel Pharmaceuticals at Motley Fool |
| 11:05AM | AstraZeneca Arthritis Drug Underperforms In Trial at Investor's Business Daily |
| 10:40AM | AstraZenecas Arthritis Pill Fails to Meet One End Goal in Late-Stage Trial at Fox Business |
| 10:19AM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 09:48AM | UPDATE 3-AstraZeneca, Rigel arthritis pill disappoints again at Reuters |
| 09:00AM | On The Fly: Pre-market Movers theflyonthewall.com |
| 08:48AM | Rigel Sinks as Arthritis Medicine Shows Mixed Results at Bloomberg |
| 08:33AM | Government slowdown hammers F5 optionMONSTER |
| 08:33AM | F5 hammered by government slowdown optionMONSTER |
| 07:08AM | Rigel Pharmaceuticals downgraded to Market Perform from Outperform at BMO Capital theflyonthewall.com |
| 05:22AM | Astra, Rigel Arthritis Pill Posts Mixed Trial Results at TheStreet |
| 03:09AM | AstraZeneca Arthritis Medicine Has Mixed Results in Trial at Bloomberg |
| 02:51AM | UPDATE 1-AstraZeneca arthritis drug meets one of two study goals at Reuters |
| 02:01AM | AstraZeneca Announces Top-Line Results From OSKIRA-1 Phase 3 Study of Fostamatinib in Rheumatoid Arthritis PR Newswire |
| 26-Mar-13 02:06PM | Pivotal Phase III Trial Data Ahead For 3 Development-Stage Small Pharma Companies at Seeking Alpha |
| 09-Mar-13 01:04PM | RIGEL PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 06-Mar-13 12:47PM | Loss at Rigel Narrower Than Expected Zacks +6.47% |
| 09:06AM | Company News for March 06, 2013 Zacks |
| 08:41AM | Rigel Pharmaceuticals: 7 Reasons To Buy This $7 Drug Stock at Seeking Alpha |
| 05-Mar-13 04:07PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 01:51PM | RIGEL PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 07:33AM | InPlay: Rigel Pharma beats by $0.02 Briefing.com |
| 07:30AM | Rigel Announces Fourth Quarter and Year End 2012 Financial Results PR Newswire |
| 28-Feb-13 07:30AM | Rigel Announces Participation at Two Investor Conferences PR Newswire |
| 19-Feb-13 10:55AM | Call strategy wagers on Rigel rebound optionMONSTER |
| 14-Feb-13 04:14PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh EDGAR Online |
| 07-Feb-13 07:30AM | Rigel to Present at BIO CEO & Investor Conference PR Newswire |
| 13-Jan-13 02:26PM | JPMorgan Healthcare Conference Rewind: Rigel Pharmaceuticals at Motley Fool |
| 07-Jan-13 09:37AM | 3 Health Care Companies I'm Watching Today at Motley Fool |
| 03-Jan-13 10:48AM | Snag RIGL 31.5% Lower Than Its Secondary? at Forbes |
| 07:37AM | Why Rigel Pharmaceuticals Lost Big in December at Motley Fool |
| 07:30AM | Rigel to Focus on Extensive Clinical Pipeline at Upcoming J.P. Morgan Presentation PR Newswire |
| 28-Dec-12 11:39AM | Molecular Diagnostic Based Therapies Create Defensive Fiscal Cliff Resistant Biotech Portfolio Strategy Wall Street Transcript |
| 21-Dec-12 11:05AM | 3 Stocks to Get on Your Watchlist at Motley Fool |
| 19-Dec-12 05:12PM | Rigel Recovers On 2013 Hope For Its Rheumatoid Arthritis Drug at Seeking Alpha |
| 17-Dec-12 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 01:22PM | Nasdaq stocks posting largest percentage increases AP |
| 09:35AM | This Week in Biotech at Motley Fool |
| 14-Dec-12 08:39PM | 3 Horrendous Health-Care Stocks This Week at Motley Fool +18.33% |
| 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 05:09PM | AstraZeneca's RA Drug Disappoints Zacks |
| 02:32PM | Danaher Target Raised Following Investors Day and 4 Stock Analyses Attracting Attention at Wall St. Cheat Sheet |
| 01:25PM | Nasdaq stocks posting largest percentage increases AP |
| 09:46AM | Danaher Target Raised Following Investors Day and 4 Stock Analyses Attracting Attention at Wall St. Cheat Sheet |
| 09:42AM | Are these Biotech Stocks a Buy After Thursday's News? at Motley Fool |
| 08:35AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:52AM | Rigel Pharmaceuticals price target lowered to $10 from $15 at Oppenheimer theflyonthewall.com |
| 06:54AM | Why This Pharma Stock Tanked Yesterday at Motley Fool |
| 05:34AM | AstraZeneca rheumatoid arthritis drug disappoints at bizjournals.com |
| 13-Dec-12 05:43PM | Rigel dips on weak rheumatoid arthritis drug trial results at bizjournals.com -34.64% |
| 05:24PM | Good, Not Great, Isn't Good Enough at Motley Fool |
| 04:27PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 04:09PM | AstraZenecas Arthritis Drug Fails to Top Standard Therapy at Bloomberg |
| 03:44PM | Stocks Near Lows In Late Trading; Drug Stocks Sink at Investor's Business Daily |
| 02:15PM | Why Rigel Pharmaceuticals Shares Got Crushed at Motley Fool |
| 01:45PM | AstraZeneca falls as RA drug underperforms Humira AP |
| 01:36PM | The Occultation Of Rigel Pharmaceuticals at Seeking Alpha |
| 11:15AM | AstraZeneca falls on disappointing drug study AP |
| 08:16AM | BRIEF-Rigel Pharma, Astrazeneca U.S.-listed shares fall in premarket at Reuters |
| 07:30AM | AstraZeneca Announces Top-Line Results of OSKIRA-4 Phase IIb Study of Fostamatinib as a Monotherapy for Rheumatoid Arthritis PR Newswire |
| 04:27AM | UPDATE 2-AstraZeneca arthritis drug lags Abbott's Humira in test at Reuters |
| 02:46AM | UPDATE 1-AstraZeneca arthritis drug worse than Humira in study at Reuters |
| 29-Nov-12 06:07PM | Charter Initiated at Buy and 4 Initiated Ratings to Notice Now at Wall St. Cheat Sheet |
| 02:47PM | Charter Initiated at Buy and 4 Initiated Ratings to Notice Now at Wall St. Cheat Sheet |
| 02:14AM | Coverage initiated on Rigel Pharms by UBS Briefing.com |
| 09-Nov-12 01:04PM | RIGEL PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 08-Nov-12 07:30AM | Rigel to Present at Jefferies 2012 Global Healthcare Conference in London PR Newswire |
| 07-Nov-12 03:45PM | Analyst Trims Vivus Target and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 02:12PM | Rigel Pharma Inspires Confidence and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 10:31AM | Rigel Pharma Inspires Confidence and 4 Stock Analyses Making Rounds at Wall St. Cheat Sheet |
| 09:36AM | New Star Analyst Rankings for Rigel Pharmaceuticals, Inc. StarMine |
| 06-Nov-12 05:58PM | Endo Pharm Reiterated at Hold and 3 Reiterated Ratings to Note at Wall St. Cheat Sheet |
| 04:06PM | RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online |
| 02:47PM | Devon Energy Faces Negative Sentiment and 4 Must-See Stock Analyses at Wall St. Cheat Sheet |
| 01:43PM | Endo Pharm Reiterated at Hold and 3 Reiterated Ratings to Note at Wall St. Cheat Sheet |
| 10:25AM | Devon Energy Faces Negative Sentiment and 4 Must-See Stock Analyses at Wall St. Cheat Sheet |
| 08:06AM | Rigel Pharmaceuticals risk/reward favorable, says Oppenheimer theflyonthewall.com |
| 08:01AM | RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
